Nifty 50
- Apollo Hospitals₹8,027.50361.50 (4.72%)
- BSE₹3,287.20-47.60 (-1.43%)
- ITC₹26611.00 (4.31%)
- Reliance Industries₹1,170.30-7.70 (-0.65%)
- Eicher Motors₹7,050282.50 (4.17%)
- JSW Steel₹1,168-7.20 (-0.61%)
- TCS₹2,15680.00 (3.85%)
- Cipla₹1,301-5.80 (-0.44%)
- HCL Technologies₹1,216.7039.80 (3.38%)
- Adani Ports₹1,76153.00 (3.10%)
- Infosys₹1,023.4026.40 (2.65%)
- Shriram Finance₹940.4523.20 (2.53%)
- Tata Motors PV₹279.906.90 (2.53%)
- UltraTech Cement₹10,675249.00 (2.39%)
- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Algo Strategy
- Markets
Stocks
F&O
Mutual Funds
- More
Open Free Demat Account
Open Free Demat Account
Gland Pharma Share Price Today
As of 09-10-2026 04:27, Gland Pharma Ltd. share price today is ₹0, with a change of ₹-3079.10 (-100.00%) from the previous close of ₹3079.1. The stock opened at ₹3059.1 and traded between ₹3008.2 and ₹3121.9, with a total traded volume of 181216 shares. The company has a market capitalization of ₹50808.5 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹3171 and ₹1573.6, respectively.
Gland Pharma Ltd. valuation metrics include a P/E ratio of 45, EPS of ₹62.35, and book value of ₹4.80. Profitability indicators show ROE of 9.91% along with a dividend yield of 0.6%. Gland Pharma Ltd. has reported revenue of ₹6725.3 Cr and net profit of ₹1128.79 Cr.
Gland Pharma Ltd. technical indicators include Day RSI at 61.23, Day MFI at 63.55, Day ADX at 28.45. Additional indicators include Commodity Channel Index (CCI) at 214.2 and Williams %R at -27.9. Momentum indicators show Day MACD at 50.72, Day MACD Signal Line at 39.02, DayATR at 95.51. Rate of Change indicators for Gland Pharma Ltd. include ROC125 at 78.14 and ROC21 at 3.52.
Exponential moving averages include EMA5 at ₹3033.6, EMA10 at ₹2989.5, EMA12 at ₹2979.4, EMA20 at ₹2949.9, EMA26 at ₹2928.7, EMA50 at ₹2827.3, EMA100 at ₹2614.3, EMA200 at ₹2345.2. Simple moving averages include SMA5 at ₹3004.3, SMA10 at ₹2962.1, SMA20 at ₹2943.8, SMA30 at ₹2931.4, SMA50 at ₹2854.4, SMA100 at ₹2600.9, SMA150 at ₹2314.5, SMA200 at ₹2175.3.
Support levels for Gland Pharma are placed at First Support ₹3028.90, Second Support ₹2978.70, Third Support ₹2907.90. Resistance levels are seen at First Resistance ₹3149.90, Second Resistance ₹3220.70, Third Resistance ₹3270.90. Gland Pharma Ltd. shareholding pattern shows promoter holding at 51.77%, FII holding at 8.74%, DII holding at 0%, public holding at 9.06%.
Gland Pharma Performance
Price Movement
₹3008.20
₹3121.90
1 Year Performance
₹1573.60
₹3171.00
Markets Today
Historical Performance
Gland Pharma Fundamentals
Gland Pharma Financials
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 1,286.64 | 1,261.59 | 1,177.51 | 1,074.15 | 1,038.84 |
| Operating Expense | 813.13 | 753.88 | 755.89 | 699.26 | 679.99 |
| Operating Profit | 473.51 | 507.72 | 421.63 | 374.89 | 358.84 |
| Depreciation | 43.95 | 43.11 | 44.53 | 44.84 | 43.77 |
| Interest | 0.69 | 6.16 | 0.50 | 3.97 | 7.44 |
| Tax | 123.30 | 144.35 | 104.61 | 106.68 | 93.12 |
| Net Profit | 364.39 | 420.45 | 307.85 | 302 | 269.26 |
Gland Pharma Technicals
Gland Pharma Ltd. EMA & SMA
₹3058.00
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
Gland Pharma Support and Resistance
Resistance
Support
Technical Indicators
Gland Pharma Shareholding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 51.8 | 51.8 | 51.8 | 51.8 | 51.8 | 51.8 |
| FII | 6.9 | 7.4 | 7.9 | 7.6 | 7.3 | 8.7 |
| DII | 33.3 | 32.8 | 32.6 | 33 | 33.3 | 30.5 |
| Public | 8 | 7.9 | 7.6 | 7.6 | 7.5 | 9.1 |
Gland Pharma Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 2.57 L | 5.47 L | 47.02% |
| Week | 3.61 L | 7 L | 51.61% |
| 1 Month | 3.49 L | 5.96 L | 58.51% |
| 6 Month | 4.03 L | 7.85 L | 51.39% |
Gland Pharma SWOT Analysis
Benjamin Graham Value Screen
Strong Performer, Getting Expensive (DVM)
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
Companies with high TTM EPS Growth
Stringent DVM Screener
Weekly Screener: High Momentum Score Stocks (subscription)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Increasing Revenue every quarter for the past 3 quarters
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Near 52 Week High
RSI indicating price strength
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter
Gland Pharma Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 11 Aug, 2026 | 20 | FINAL | 11 Aug, 2026 | Equity Share |
| 14 Aug, 2025 | 18 | FINAL | 14 Aug, 2025 | Equity Share |
| 16 Aug, 2024 | 20 | FINAL | 16 Aug, 2024 | Equity Share |
Gland Pharma Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,550 | ₹865.90 | ₹1,490.30 | ₹1,835 | ₹2,368.50 | ₹197.15 |
| % Change | 0.95% | -0.76% | -1.02% | -0.89% | -0.48% | 0.37% |
| Revenue TTM (₹ Cr) | ₹1,935.80 | ₹2,002.34 | ₹2,250.36 | ₹9,683.45 | ₹14,737.88 | ₹9,205.28 |
| Net Profit TTM (₹ Cr) | ₹288.22 | ₹575.94 | ₹361.74 | ₹1,011.39 | ₹2,042.67 | ₹-313.62 |
| PE TTM | 88.20 | 85.30 | 88.40 | 34.70 | 48.10 | -83.40 |
| 1 Year Return | 216.58 | 13.13 | 75.99 | 34 | -3.05 | 1.36 |
| ROCE | 24.32 | 27.56 | 18.38 | 25.65 | 14.32 | 2.29 |
Similar Stocks
ACUTAAS
Acutaas Chemicals Ltd.
₹ 3160.10
+3.38%
LAURUSLABS
Laurus Labs Ltd.
₹ 2036.60
+1.94%
ALKEM
Alkem Laboratories Ltd.
₹ 5279.00
+0.56%
BIOCON
Biocon Ltd.
₹ 349.40
-0.17%
DIVISLAB
Divi's Laboratories Ltd.
₹ 9340.00
-0.22%
GRANULES
Granules India Ltd.
₹ 814.00
-0.13%
AJANTPHARM
Ajanta Pharma Ltd.
₹ 3405.00
-0.89%
ZYDUSLIFE
Zydus Lifesciences Ltd.
₹ 1117.50
+0.49%
GLENMARK
Glenmark Pharmaceuticals Ltd.
₹ 2293.00
+4.60%
WOCKPHARMA
Wockhardt Ltd.
₹ 2001.00
-1.41%
SHILPAMED
Shilpa Medicare Ltd.
₹ 1025.60
+0.03%
AUROPHARMA
Aurobindo Pharma Ltd.
₹ 1693.00
+2.92%
SUNPHARMA
Sun Pharmaceutical Industries Ltd.
₹ 1760.00
+0.01%
NEULANDLAB
Neuland Laboratories Ltd.
₹ 20830.00
-0.88%
IPCALAB
Ipca Laboratories Ltd.
₹ 1912.00
-1.36%
GLAXO
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2532.10
-0.09%
ABBOTINDIA
Abbott India Ltd.
₹ 25950.00
+1.45%
TORNTPHARM
Torrent Pharmaceuticals Ltd.
₹ 4656.90
+0.86%
LUPIN
Lupin Ltd.
₹ 1956.50
+1.01%
DRREDDY
Dr. Reddy's Laboratories Ltd.
₹ 1197.00
+1.44%
CIPLA
Cipla Ltd.
₹ 1301.00
-0.44%
FAQ's on GLAND
What is the current share price of Gland Pharma Ltd.?
What is the Market Capitalization of Gland Pharma Ltd.?
What are the PE and PB ratios for Gland Pharma Ltd.?
What is the 52-Week High and Low for Gland Pharma Ltd.?
What is the current dividend yield for Gland Pharma Ltd.?
Who are the major shareholders of Gland Pharma Ltd.?
Who are the peers of Gland Pharma Ltd. in the Pharmaceuticals & Biotechnology sector?
What is the latest dividend information for Gland Pharma Ltd.?
Invest Anytime, Anywhere
By signing up I certify terms, conditions & privacy policy